4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-106530
COO & CBO sold 30,000 shares at $4.51 ($135,330)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hexter Joshua COO & CBO | 2026-10-01 | Sale 10b5-1 | −30,000 | $4.51 | $135,330 | 1,328,130 | D |
| Open-market sales · 30,000 sh · avg $4.51 · $135,330 | |||||||
Loading xslF345X06/ownership.xml…